Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Clin J Oncol Nurs ; 20(5): AE-2, 2016 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-27668381

RESUMO

BACKGROUND: Patients with brain metastasis (BM) usually suffer from poor quality of life (QOL), anxiety, depression, and sleep disorders in their reduced lifespan. OBJECTIVES: The aim of this study was to evaluate QOL, anxiety, depression, and sleep characteristics in patients with BM at the beginning and end of whole brain radiation therapy (WBRT) and three months after treatment. METHODS: Thirty-three patients undergoing WBRT for BM were featured in this study. The authors used the Karnofsky Performance Status (KPS) scale to measure performance status, the Hospital Anxiety and Depression Scale (HADS) to evaluate anxiety and depression, the SF-36® to evaluate health-related QOL, and the Pittsburgh Sleep Quality Index to evaluate sleep disorders at the start of WBRT, the end of WBRT, and three months after WBRT. FINDINGS: Statistically significant improvements were noted in KPS scores from baseline evaluation to the end of WBRT and to three months after WBRT. No significant differences were observed in SF-36 and HADS scores between the start and the end of WBRT. Anxiety scores were negatively correlated with survival at the end of WBRT. Overall survival was better in those who reported better sleep. WBRT improves KPS scores and does not worsen sleep quality or mood, even in patients with poor performance status. When changes in mood and sleep quality are observed, survival and QOL may improve in patients with BM; consequently, nurses should be responsive to these changes.


Assuntos
Neoplasias Encefálicas/complicações , Neoplasias Encefálicas/terapia , Terapia por Estimulação Elétrica , Campos Eletromagnéticos , Metástase Neoplásica/terapia , Pacientes/psicologia , Transtornos do Sono-Vigília/etiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Qualidade de Vida , Estresse Psicológico/etiologia
2.
Medicine (Baltimore) ; 94(3): e413, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25621689

RESUMO

Pulmonary tuberculosis (PT) has been previously related with various psychosocial adverse consequences including stigmatization and social isolation.Social anxiety is a psychiatric condition that may be associated with social isolation and fear of social exclusion.To date no study has investigated social anxiety and its impact on quality of life (QoL) among patients with PT. Therefore, we aimed to determine the severity of social anxiety in a group of patients with PT.Among patients who were recently discharged from hospital with the diagnosis of PT 94 patients and 99 healthy control subjects who had similar demographical features have been included in the study. A psychiatrist interviewed all participants and a semistructured interview form, which was prepared by the authors, Liebowitz Social Anxiety Scale (LSAS), and Short Form-36 were administered to them.Patients with PT showed higher levels of performance avoidance and social avoidance than healthy control subjects. They reported lower QoL scores across all dimensions. Among patients women showed higher levels of LSAS subscale scores and total score. Fear of social exclusion was predicted by perceived illness severity and emotional role difficulty. On the other hand, perceived illness severity was predicted by fear of exclusion and sedimentation level.PT patients seem to experience higher levels of social anxiety and associated fear of social exclusion that add to their worse QoL during the earlier months of their disease. Among them fear of social exclusion is related with perceived illness severity.


Assuntos
Ansiedade/epidemiologia , Psicologia , Qualidade de Vida/psicologia , Tuberculose Pulmonar/psicologia , Adolescente , Adulto , Estudos de Casos e Controles , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Autoimagem , Índice de Gravidade de Doença , Isolamento Social/psicologia , Adulto Jovem
3.
Ren Fail ; 34(9): 1150-5, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22950656

RESUMO

AIM: The aim of this study was to investigate the protective effect of caffeic acid phenethyl ester (CAPE) on acetylsalicylic acid (ASA)-induced renal damage in rats. MATERIALS AND METHODS: A total of 40 rats were randomly divided into five groups, with eight rats in each group-group 1: control, not receiving any medication; group 2: ASA (50 mg/kg/day); group 3: ASA (50 mg/kg/day) + CAPE (20 µg/kg/day); group 4: ASA (100 mg/kg/day); and group 5: ASA (100 mg/kg/day) + CAPE (20 µg/kg/day). ASA and CAPE were given via orogastric gavage for 5 days. The total oxidant status (TOS), total antioxidant capacity (TAC), and paraoxonase-1 (PON-1) activity of the blood samples and kidney tissues were determined. Histopathological examinations of the kidneys were performed using light microscopic methods. RESULTS: The TOS level in the serum of rats and kidney tissues given ASA (groups 2 and 4) significantly increased, but the levels of TAC and PON-1 in these tissues significantly decreased in group 4 when compared with the control rats (p < 0.05). The levels of TAC and PON-1 in the kidney tissues increased and the levels of TOS decreased in the CAPE treatment groups (groups 3 and 5) when compared with the rats in the no CAPE treatment groups (groups 2 and 4). The PON-1, TAC, and TOS values reverted to normal levels in group 5 when compared to group 4 (p < 0.05). These results were supported by histopathological observation. CONCLUSION: Oxidative stress plays an important role in ASA-induced nephrotoxicity, and CAPE may protect against ASA-induced nephrotoxicity in rats.


Assuntos
Injúria Renal Aguda/prevenção & controle , Aspirina/toxicidade , Ácidos Cafeicos/administração & dosagem , Rim/patologia , Álcool Feniletílico/análogos & derivados , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/metabolismo , Animais , Ácidos Cafeicos/farmacocinética , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Feminino , Rim/efeitos dos fármacos , Rim/metabolismo , NF-kappa B/antagonistas & inibidores , Estresse Oxidativo/efeitos dos fármacos , Álcool Feniletílico/administração & dosagem , Álcool Feniletílico/farmacocinética , Ratos , Ratos Wistar
4.
Int J Neurosci ; 122(7): 367-72, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22248035

RESUMO

To date, there have not been enough studies about the effects of curcumin against oxidative stress on sciatic nerves caused by streptozotocin (STZ) in diabetic rats. Therefore, this study was undertaken to determine whether curcumin, by virtue of its antioxidant properties, could affect the oxidant/antioxidant balance in the sciatic nerve and brain tissues of streptozotocin (STZ)-induced diabetic rats. A total of 28 rats were randomly divided into four groups of seven rats each: normal controls, only curcumin treated, diabetic controls, and diabetics treated with curcumin. Biomarkers-malondialdehyde (MDA), total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), and NO levels-for oxidative stress in the brain and sciatic nerve tissues of the rats were measured. We found a significant increase in MDA, NO, TOS, and OSI, along with a reduction in TAS levels in the brains and sciatic nerves of the STZ-induced diabetic rats (for both parameters p < 0.05). The MDA, TOS, OSI, and NO levels in these tissues were significantly reduced in the curcumin-treated diabetic group compared to the untreated diabetic group. In conclusion, the results of this study suggested that curcumin exhibits neuroprotective effects against oxidative damage in the brain and sciatic tissues of diabetic rats.


Assuntos
Encéfalo/metabolismo , Curcumina/uso terapêutico , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/patologia , Estresse Oxidativo/efeitos dos fármacos , Nervo Isquiático/metabolismo , Animais , Encéfalo/efeitos dos fármacos , Cromanos , Modelos Animais de Doenças , Feminino , Peróxido de Hidrogênio/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Malondialdeído/metabolismo , Óxido Nítrico/metabolismo , Oxirredução/efeitos dos fármacos , Ratos , Ratos Wistar , Nervo Isquiático/efeitos dos fármacos
5.
Cell Biochem Funct ; 29(6): 506-12, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21735456

RESUMO

We examined the relationships of glucose and HbA1c levels with the routinely screened serum enzyme activities in type 2 diabetes mellitus, and we designed an in vitro study to evaluate the direct effect of glucose levels on enzyme activities. The study was performed on a consecutive series of outpatients with type 2 diabetes who were followed up at Dicle University Medical Faculty Hospital from May 2009 to May 2010 for the first time. Effects of aspartate transaminase, aminotransferase, gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH) activities, glucose and HbA1c levels and in vitro glucose (492, 287, 184, 131, 82 mg dl⁻¹, respectively) on enzymes were determined. The patients were categorized on the basis of glucose and HbA1c levels and grouped according to a range of values. In patients with high HbA1c levels (>10.1%), ALP, GGT activities and creatine kinase (CK)-MB/CK (p = 0.008, 0.026, 0.014) ratio were increased significantly when compared with those in the control group. In patients with high glucose levels (> 200 mg dl⁻¹), ALP, GGT activities and CK-MB/CK ratio (p = 0.003, 0.001, 0.001) were increased significantly when compared with those in the control group. Glucose, which was added to serum in different concentrations in vitro, did not directly affect enzyme activities such as ALP, GGT and CK. We concluded that increased glucose levels could damage the liver and the heart muscle cells. Monitoring of blood glucose levels is a more valuable parameter than monitoring HbA1c in the momentary evaluation of diabetes.


Assuntos
Biomarcadores/sangue , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/enzimologia , Idoso , Alanina Transaminase/sangue , Fosfatase Alcalina/sangue , Aspartato Aminotransferases/sangue , Glicemia/análise , Feminino , Hemoglobinas Glicadas/análise , Humanos , L-Lactato Desidrogenase/sangue , Masculino , Pessoa de Meia-Idade , Monitorização Fisiológica , Estudos Retrospectivos , gama-Glutamiltransferase/sangue
6.
Turk J Gastroenterol ; 17(1): 7-12, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16830271

RESUMO

BACKGROUND/AIMS: The objective of this study was to examine the relationship between Helicobacter pylori and constitutional height retardation in childhood. METHODS: Forty-one children with a diagnosis of constitutional height retardation and 40 children with normal growth patterns attending to the Pediatric Endocrinology Clinic at Ankara Education and Research Hospital were invited to take part in this study. Each child was asked questions to identify whether they had abdominal pain or lack of appetite. In addition, the family members were also investigated for gastrointestinal complaints. Helicobacter pylori antibody levels were evaluated in both groups. RESULTS: The patient group's anti-Helicobacter pylori Ig G and anti-Helicobacter pylori CagA Ig G positivities were 78% and 85.4%, respectively. Corresponding frequencies in the control group were 10% and 15%, respectively. CONCLUSION: The seroprevalence of Helicobacter pylori antibodies in the constitutional height-retarded group was significantly higher than in the control group (p<0.001). These results support the hypothesis suggesting that Helicobacter pylori infection is one of the environmental factors affecting growth.


Assuntos
Transtornos do Crescimento/etiologia , Infecções por Helicobacter/complicações , Helicobacter pylori , Adolescente , Anticorpos Antibacterianos/análise , Criança , Pré-Escolar , Feminino , Transtornos do Crescimento/microbiologia , Helicobacter pylori/imunologia , Humanos , Imunoglobulina G/análise , Masculino , Estudos Soroepidemiológicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA